Steve Pedrini

4.5k total citations · 3 hit papers
43 papers, 2.8k citations indexed

About

Steve Pedrini is a scholar working on Physiology, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Steve Pedrini has authored 43 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Physiology, 14 papers in Molecular Biology and 10 papers in Psychiatry and Mental health. Recurrent topics in Steve Pedrini's work include Alzheimer's disease research and treatments (30 papers), Dementia and Cognitive Impairment Research (9 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Steve Pedrini is often cited by papers focused on Alzheimer's disease research and treatments (30 papers), Dementia and Cognitive Impairment Research (9 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Steve Pedrini collaborates with scholars based in United States, Australia and United Kingdom. Steve Pedrini's co-authors include Federico Licastro, Sam Gandy, Ralph N. Martins, Cinzia Ferri, Valeria M. Casadei, Luigi Grimaldi, Pratishtha Chatterjee, Hamid R. Sohrabi, Lizabeth Jane Davis and Giorgio Annoni and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Steve Pedrini

43 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neuronal SIRT1 Activation as a Novel Mechanism Underlying the Prevention of Alzheimer Disease Amyloid Neuropathology by Calorie Restriction

2006 522 citations Steve Pedrini, Sam Gandy et al. profile →
Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease

2021 276 citations Pratishtha Chatterjee, Steve Pedrini et al. Translational Psychiatry profile →
Plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross‐sectional and longitudinal study in the AIBL cohort

2022 155 citations Pratishtha Chatterjee, Steve Pedrini et al. Alzheimer s & Dementia profile →

Peers

Countries citing papers authored by Steve Pedrini

Since Specialization

Citations

This map shows the geographic impact of Steve Pedrini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Pedrini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Pedrini more than expected).

Fields of papers citing papers by Steve Pedrini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Pedrini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Pedrini. The network helps show where Steve Pedrini may publish in the future.

Co-authorship network of co-authors of Steve Pedrini

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Pedrini. A scholar is included among the top collaborators of Steve Pedrini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Pedrini. Steve Pedrini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort 2024 ·Journal of Neurology ·Dhamidhu Eratne, Qiao-Xin Li, Courtney Lewis, Christa Dang, (unknown), (unknown), Samantha M. Loi, Mark Walterfang, Andrew Evans, Charles B. Malpas, Steve Pedrini, Ralph N. Martins, Pratishtha Chatterjee, Henrik Zetterberg, Kaj Blennow, Samuel F. Berkovic, Alexander Santillo, Steven Collins, Colin L. Masters, Dennis Velakoulis, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	4
2	The impact of exercise on blood-based biomarkers of Alzheimer’s disease in cognitively unimpaired older adults 2024 ·GeroScience ·Kelsey R. Sewell, Stephanie R. Rainey‐Smith, Steve Pedrini, Jeremiah J. Peiffer, Hamid R. Sohrabi, Kevin Taddei, (unknown), Ralph N. Martins, Belinda M. Brown	11
3	Plasma high‐density lipoprotein cargo is altered in Alzheimer's disease and is associated with regional brain volume 2022 ·Journal of Neurochemistry ·Steve Pedrini, James D. Doecke, Eugene Hone, Penghao Wang, Rohith N. Thota, Ashley I. Bush, Christopher C. Rowe, Vincent Doré, Victor L. Villemagne, David Ames, Stephanie R. Rainey‐Smith, Giuseppe Verdile, Hamid R. Sohrabi, Manfred Raida, Kevin Taddei, Sam Gandy, Colin L. Masters, Pratishtha Chatterjee, Ralph N. Martins	13
4	Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease breakdown → 2021 ·Translational Psychiatry ·Pratishtha Chatterjee, Steve Pedrini, Erik Stoops, Kathryn Goozee, Victor L. Villemagne, Prita R. Asih, Inge M.W. Verberk, Preeti Dave, Kevin Taddei, Hamid R. Sohrabi, Henrik Zetterberg, Kaj Blennow, Charlotte E. Teunissen, Hugo Vanderstichele, Ralph N. Martins	276
5	Serum Hepcidin Levels in Cognitively Normal Older Adults with High Neocortical Amyloid-β Load 2020 ·Journal of Alzheimer s Disease ·Pratishtha Chatterjee, Maryam Mohammadi, Kathryn Goozee, Tejal Shah, Hamid R. Sohrabi, Cintia B. Dias, Kaikai Shen, Prita R. Asih, Preeti Dave, Steve Pedrini, Nicholas J. Ashton, Abdul Hye, Kevin Taddei, David B. Lovejoy, Henrik Zetterberg, Kaj Blennow, Ralph N. Martins	7
6	Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer’s Disease Patients and Correlates with Cognitive Performance 2020 ·Journal of Alzheimer s Disease ·Steve Pedrini, Eugene Hone, Veer Bala Gupta, Ian James, (unknown), Ashley I. Bush, Christopher C. Rowe, Victor L. Villemagne, David Ames, Colin L. Masters, Stephanie R. Rainey‐Smith, Giuseppe Verdile, Hamid R. Sohrabi, Manfred Raida, Markus R. Wenk, Kevin Taddei, Pratishtha Chatterjee, Ian Martins, Simon M. Laws, Ralph N. Martins	10
7	Potential of coconut oil and medium chain triglycerides in the prevention and treatment of Alzheimer’s disease 2020 ·Mechanisms of Ageing and Development ·Pratishtha Chatterjee, (unknown), (unknown), Cintia B. Dias, Tejal Shah, Renuka Silva, Shehan Williams, Steve Pedrini, (unknown), Kathryn Goozee, Edward Barin, Hamid R. Sohrabi, Manohar L. Garg, Stephen C. Cunnane, Ralph N. Martins	72
8	Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer’s disease 2019 ·Journal of Neuroinflammation ·Pratishtha Chatterjee, Henrik Zetterberg, Kathryn Goozee, Chai K. Lim, Kelly R. Jacobs, Nicholas J. Ashton, Abdul Hye, Steve Pedrini, Hamid R. Sohrabi, Tejal Shah, Prita R. Asih, Preeti Dave, Kaikai Shen, Kevin Taddei, David B. Lovejoy, Gilles J. Guillemin, Kaj Blennow, Ralph N. Martins	52
9	[P4–136]: IL‐10 AND IL‐12/23P40 ARE JOINTLY ASSOCIATED AS PREDICTORS OF Aβ‐AMYLOID LOAD IN A BROADER BLOOD‐BASED BIOMARKER PANEL 2017 ·Alzheimer s & Dementia ·Steve Pedrini, Veer Bala Gupta, Eugene Hone, James D. Doecke, Sid E. O’Bryant, Ian James, Ashley I. Bush, Christopher C. Rowe, Victor L. Villemagne, David Ames, Colin L. Masters, Ralph N. Martins	1
10	Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging 2015 ·Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring ·Veer Bala Gupta, James D. Doecke, Eugene Hone, Steve Pedrini, Simon M. Laws, Madhav Thambisetty, Ashley I. Bush, Christopher C. Rowe, Victor L. Villemagne, David Ames, Colin L. Masters, S. Lance Macaulay, Alan Rembach, Stephanie R. Rainey‐Smith, Ralph N. Martins	30
11	Follow-up plasma apolipoprotein E levels in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) cohort 2015 ·Alzheimer s Research & Therapy ·Veer Bala Gupta, Andrea C. Wilson, Samantha C. Burnham, Eugene Hone, Steve Pedrini, Simon M. Laws, Wei Ling Florence Lim, Alan Rembach, Stephanie R. Rainey‐Smith, David Ames, Lynne Cobiac, S. Lance Macaulay, Colin L. Masters, Christopher C. Rowe, Ashley I. Bush, Ralph N. Martins	17
12	Dietary composition modulates brain mass and solubilizable Aβ levels in a mouse model of aggressive Alzheimer's amyloid pathology 2009 ·Molecular Neurodegeneration ·Steve Pedrini, (unknown), Hannah Brautigam, James Schmeidler, Lap Ho, Paul Fraser, David Westaway, Peter St George‐Hyslop, Ralph N. Martins, Joseph D. Buxbaum, Giulio Maria Pasinetti, Dara L. Dickstein, Patrick R. Hof, Michelle E. Ehrlich, Sam Gandy	39
13	Phosphatidylinositide 3‐kinase and protein kinase C zeta mediate retinoic acid induction of DARPP‐32 in medium size spiny neurons in vitro 2008 ·Journal of Neurochemistry ·Steve Pedrini, Alexey Bogush, Michelle E. Ehrlich	6
14	Evidence against roles for phorbol binding protein Munc13-1, ADAM adaptor Eve-1, or vesicle trafficking phosphoproteins Munc18 or NSF as phospho-state-sensitive modulators of phorbol/PKC-activated Alzheimer APP ectodomain shedding 2007 ·Molecular Neurodegeneration ·Annat Ikin, Mirsada Čaušević, Steve Pedrini, Lyndsey S. Benson, Joseph D. Buxbaum, Toshiharu Suzuki, Simon Lovestone, Shigeki Higashiyama, Tomas Mustelin, Robert D. Burgoyne, Sam Gandy	14
15	Brain neprilysin activity and susceptibility to transgene-induced Alzheimer amyloidosis 2005 ·Neuroscience Letters ·Troy L. Carter, Steve Pedrini, Jorge Ghiso, Michelle E. Ehrlich, Sam Gandy	23
16	Polymorphism in the alpha1-antichymotrypsin (ACT) gene promoter: effect on expression in transfected glial and liver cell lines and plasma ACT concentrations 2001 ·Human Genetics ·Kevin Morgan, Federico Licastro, Louise Tilley, (unknown), Linda Morgan, Steve Pedrini, Noor Kalsheker	25
17	Blood Levels of Alpha-1-Antichymotrypsin and Risk Factors for Alzheimer’s Disease: Effects of Gender and Apolipoprotein E Genotype 2000 ·Dementia and Geriatric Cognitive Disorders ·Federico Licastro, Eliezer Masliah, Steve Pedrini, Leon J. Thal	136
18	Increased plasma levels of interleukin-1, interleukin-6 and α-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain? 2000 ·Journal of Neuroimmunology ·Federico Licastro, Steve Pedrini, Ludovica Caputo, Giorgio Annoni, Lizabeth Jane Davis, Cinzia Ferri, Valeria M. Casadei, Luigi Grimaldi	339
19	Apolipoprotein E and α-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease 1999 ·Neuroscience Letters ·Federico Licastro, Steve Pedrini, Marzia Govoni, Annalisa Pession, Cinzia Ferri, G Annoni, Valeria M. Casadei, Fabrizio Veglia, Stefano Bertolini, Luigi M.E. Grimaldi	38
20	Prostaglandin E2 Induced Polymerization of Human α-1-Antichymotrypsin and Suppressed Its Protease Inhibitory Activity: Implications for Alzheimer's Disease 1998 ·Biochemical and Biophysical Research Communications ·Federico Licastro, Lizabeth Jane Davis, Steve Pedrini, Douglas Galasko, (unknown)	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact